CA Patent

CA2765852C — Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections

Assigned to Curofin Pharma GmbH · Expires 2014-08-26 · 12y expired

What this patent protects

The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprisi…

USPTO Abstract

The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprising finafloxacin or a finafloxacin derivative. The compositions are suitable for the treatment of ophthalmic, otic, or nasal infections.

Drugs covered by this patent

Patent Metadata

Patent number
CA2765852C
Jurisdiction
CA
Classification
—
Expires
2014-08-26
Drug substance claim
No
Drug product claim
No
Assignee
Curofin Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.